Table 2.

Clinical pathological features related with HSPB1 expression according to logistic regression analysis

Characteristics	Total(N)	Odds Ratio(OR)	P value
Age (> 60 vs. <  = 60)	1,083	1.211 (0.953–1.540)	0.118
T stage (T3&T4 vs. T1&T2)	1,080	1.322 (0.955–1.836)	0.093
N stage (N1&N2&N3 vs. N0)	1,064	1.427 (1.121–1.818)	0.004
M stage (M1 vs. M0)	922	1.625 (0.666–4.182)	0.293
Pathologic stage (Stage III&Stage IV vs. Stage I&Stage II)	1,060	1.516 (1.144–2.014)	0.004
ER status (Positive vs. Negative)	1,033	4.950 (3.561–6.982)	< 0.001
PR status (Positive vs. Negative)	1,030	2.639 (2.019–3.464)	< 0.001
HER2 status (Positive vs. Negative)	715	1.136 (0.797–1.620)	0.480
radiation_therapy (Yes vs. No)	987	1.171 (0.910–1.506)	0.219

TMN stage was according to the seventh edition of the Guidelines for the American Journal of Critical Care. ER estrogen receptor, PR progesterone receptor, HER2 human epidermal growth factor receptor. Bold values indicate that p < 0.05